Skip to search.
 FTSE 100 Up 0.48%
Streaming
Ticker Tape: On

Theravance Inc. (THRX)

-NasdaqGS
27.19 15 Apr 21:00
Add to Portfolio
Prev Close:27.19
Open:N/A
Bid:27.01 x 200
Ask:29.00 x 100
1y Target Est:42.00
Beta:0.68
Earnings Date:21 Apr - 25 Apr (Est.)
Day's Range:N/A - N/A
52wk Range:26.04 - 42.96
Volume:65
Avg Vol (3m):998,702
Market Cap:3.04b
P/E (ttm):N/A
EPS (ttm):-1.67
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):87.71
P/S (ttm):639.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.22
Quarterly EPS Est (Mar-14) :-0.53
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system/pain. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback